Medicinal Product 
End-to-end support from experienced Regulatory experts.

Medicinal Products Regulatory Support in Singapore- Overview

Singapore’s pharmaceutical market is one of the most advanced in Asia-Pacific, governed by internationally harmonized frameworks aligned with ICH, PIC/S, and ASEAN guidelines.

The Health Sciences Authority Singapore ensures that all medicinal products meet established standards of quality, safety, and efficacy before granting Marketing Authorization Singapore.

To complete Product registration in Singapore HSA, companies must:

• Submit ACTD or CTD-compliant dossiers via PRISM
• Provide valid GMP certification
• Comply with labeling and package insert regulations
• Meet Pharmacovigilance requirements Singapore
• Align with local advertising controls

We support manufacturers and innovators across the entire Singapore drug approval process, ensuring dossier accuracy and Regulatory alignment for timely approvals.

Medicinal Product Classification in Singapore

Under HSA regulations, medicinal products are classified as:

• Prescription Medicines (POM): Require prescription, full dossier, and HSA approval.
• Pharmacy-Only Medicines (P): Can be supplied by a pharmacist without a doctor’s prescription.
• General Sale List Medicines (GSL): Considered safe for self-selection and public sale.
• Over the Counter (OTC) Medicines: Similar requirements as POMs for non-prescription status; classification must be supported by documentation from a recognized reference agency.
• Biologicals/Biosimilars: Subject to detailed comparability and stepwise nonclinical/clinical evaluation.
• Controlled Drugs: Regulated under the Misuse of Drugs Act — require special licenses and controls.
• Herbal/Natural Products & Chinese Proprietary Medicines (CPM): Separate product listing requirements under CPM Guidelines; full dossier, local clinical use, and labeling compliance required.

All medicinal products must undergo Singapore pharmaceutical product registration before importation, distribution, or commercialization.

Medicinal Product Registration & Approval Process in Singapore

Regulatory Authority: Health Sciences Authority (HSA)
Legislation: Health Products Act, Medicines Act, HSA Guidelines, ICH & ASEAN Guidelines

Key Steps

1. Licensing

• Foreign manufacturers must appoint a local Registrant / Product Owner in Singapore.
• Manufacturing facilities must comply with PIC/S GMP standards acceptable to HSA.

2. Dossier Submission 

Submission in ACTD or CTD format via PRISM (Pharmaceutical Regulatory Information System).

Dossier includes:

• Quality documentation (Module 3)
• Nonclinical and clinical data (Modules 4 & 5, if applicable)
• GMP certification
• Stability data
• Product labeling and package insert
• Risk Management Plan (if required)

3. Scientific Evaluation 

HSA conducts detailed evaluation of quality, safety, and efficacy.

Evaluation pathways may include:

• Full Evaluation Route
• Abridged Evaluation Route
• Verification Route (for products approved by reference agencies)

These pathways impact timelines and documentation requirements within the Singapore pharmaceutical product registration framework.

4. Approval & Registration 

Upon successful review, Marketing Authorization Singapore is issued, allowing lawful importation and commercialization.

Post-Authorization Requirements 

• Ongoing GMP compliance
• Labeling updates per HSA directives
• Import licensing compliance
• Mandatory pharmacovigilance reporting

Specific Requirements by Product Type 

• Generics: Bioequivalence studies required unless biowaiver criteria are met.
• Biologics/Biosimilars: Must comply with ICH comparability frameworks.
• Vaccines: Subject to enhanced quality and risk management review.
• OTC Products: Simplified evaluation route depending on category.

Post-Approval & Pharmacovigilance 

Approved medicinal products in Singapore are subject to ongoing HSA oversight:

• Renewals: Periodic review of benefit-risk profile.
• Variations: Prior approval required for changes in manufacturing site, formulation, labeling, or packaging.

Pharmacovigilance Obligations 

• Local Responsible Person for PV
• ADR reporting to HSA
• Risk management plan implementation
• Safety communications and recalls (if required)

We provide lifecycle Regulatory support to ensure continued compliance under HSA medicinal product registration requirements.